6281-23-8

Usage

Uses

Used in Pharmaceutical Industry:
3-(5-Nitro-2-furyl)acrylic acid is used as an intermediate in the synthesis of various pharmaceuticals for its antimicrobial and anticancer properties. It contributes to the development of drugs that target a range of diseases, including infections and cancer, by leveraging its biological activities.
Used in Agricultural Chemicals Industry:
In the agricultural sector, 3-(5-Nitro-2-furyl)acrylic acid is used as a precursor in the production of agricultural chemicals, particularly those with antimicrobial properties. Its incorporation aids in the creation of compounds that can protect crops from microbial infections, thereby enhancing crop yield and quality.
Used in Mutagenesis Research:
3-(5-Nitro-2-furyl)acrylic acid is also used as a mutagen in certain biological systems, making it a valuable tool in genetic research. Its mutagenic properties allow scientists to induce genetic variations, which can be studied to understand gene functions and mechanisms of inheritance.

Upstream product

• 698-63-5 5-nitrofurane-2-carboxaldehyde 
• 108-24-7 acetic anhydride 
• 141-82-2 malonic acid 

Downstream Products

• 57260-24-9 1-[3-(5-nitro-furan-2-yl)-acryloyl]-4-(4-oxo-5-phenyl-4,5-dihydro-oxazol-2-yl)-piperazine 
• 3967-28-0 2-[(E)-3-(5-Nitro-furan-2-yl)-acryloylamino]-3-phenyl-propionic acid ethyl ester 
• 78113-70-9 3-(4-Hydroxy-phenyl)-2-[(E)-3-(5-nitro-furan-2-yl)-acryloylamino]-propionic acid ethyl ester 
• 89076-51-7 (E)-2-(4-Nitrophenyl)-1-(5-nitro-2-furyl)ethylene 
• 89076-52-8 (E)-2-(4-Ethoxycarbonylphenyl)-1-(5-nitro-2-furyl)ethylene 
• 104431-32-5 2-(4-Nitrophenyl)-1-(5-(4-nitrophenyl)-2-furyl)ethylene 
• 100-00-5 4-chlorobenzonitrile 
• 1860-83-9 2-[2-(5-nitro-furan-2-yl)-vinyl]-5-phenyl-[1,3,4]oxadiazole 
• 71258-91-8 5-nitro-2-vinylfuran 
• 93303-56-1 (E)-ethyl-3-(2-furanyl-5-nitro)-2-propenoate 
• 145386-11-4 N-(oxiranylmethyl)-3-(5-nitrofuran-2-yl)propenamide 
• 1094617-91-0 (S)-O-methyl (3-(3-fluoro-4-(4-(3-(5-nitrofuran-2-yl)-acryloyl)-piperazin-1-yI)phenyl)-2-oxo-oxazolidin-5-yl)methylcarbamothioate 
• 1138148-73-8 C₂₃H₂₅FN₆O₇S 

Relevant academic research and scientific papers

New fluorescent crosslinked aromatic polyamides containing thiopheneand furane in their backbone

New fluorescent crosslinked aromatic polyamides containing phenylen, thiophene and furane groups in the main chain were synthesized by self-condensation from 3-(5-aminothiophen-2-yl)propenoic acid, 3-(5-aminofuran-2-yl)propenoic acid and 3-(4-((5-aminothiophen-2-yl)methyleneamino)phenyl)propenoic acid using the phosphorylation method and triphenylphosphite as initiator. The amino compounds were obtained from 3-(5-nitrothiophen-2-yl)propenoic acid, 3-(5-nitrofuran-2-yl)propenoic acid and 3-(4-((5-nitrothiophen-2-yl)methyleneamino)phenyl)propenoic by selective reduction of each nitro group and was confirmed by 1H-NMR and FT-IR spectroscopy. Crosslinking of polyamides ocurr by mechanism between vinyl side groups reacts with the vinyl carbon of another chain, giving rise to interchain linear crosslinking. Depending on the structure the polymers have higher degree of crosslinking. Some vinyl groups react by thermal treatmentat 200 °C. Partially crosslinked polyamides with high emission fluorescence were obtained. Consequently amide bond formation, crosslinking and conjugation are the main factors that influence the fluorescence process. While polymers have several factors that affect the fluorescence, we believe that the most significant is the crosslinking of vinyl bonds. Subsequent thermal treatment of polyamides provoked crosslinking increase and fluorescence loss. The effect of the chemical structure was correlated with the thermal decomposition. Polyamides were characterized by UV-visible, FT-IR and 1H-NMR spectroscopy, inherent viscosity and thermogravimetric analysis (TGA). The synthesized polyamides exhibited potential for heat sensitive devices application since the fluorescence can be activated or quenched according to a heating process.

NOVEL COMPOUNDS AND THEIR USE

The present invention provides novel compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof. The novel compounds are useful as antibacterial agents in the treatment of conditions such as nosocomial pneumonia, community acquired pneumonia, infections caused by vancomycin resistant enterococci (VRE), methicillin resistant Staphylococcus aureus (MRSA), Heamophilus influenzae (HI) and penicillin resistant Streptococcus pneumoniae (PRSP). The compounds of the present invention are effective against a number of human or animal pathogens including VRE, PRSP, HI and MRSA.

Synthesis and Evaluation of Novel Electrophilic Nitrofuran Carboxamides and Carboxylates as Radiosensitizers and Bioreductively Activated Cytotoxins

A series of 5-nitrofuran-2- and 3-carboxamides bearing alkylating side-chains has been synthesized and tested for their ability to radiosensitize selectively hypoxic Chinese hamster cells (V79) to the lethal effects of ionizing radiation and also for their ability to act directly and selectively as cytotoxic drugs on hypoxic V79 cells.The compounds were extremly efficient radiosensitizers of such cells in vitro and were more efficient than known nitroimidazoles of similar type.Their efficiencies as radiosensitizers correlated with their high electron affinity(E17) as measured by pulse-radiolysis.However the compounds showed little radiosensitizing activity towards KHT sarcomas in C3H mice.The compounds in this series of nitrofurans were generally more toxic towards hypoxic cells than towards oxic cells in vitro but were less effective upon the basis of a differential effect than were similar nitroimidazoles reported previously.